Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Neonatal Hypoxia

In brief

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Key facts

Study ID

NCT03949049

Run by

Sherief Abd-Elsalam

People needed

40

Starts

2019-02-01

Expected to finish

2029-12-01

Last updated by the study team

2019-05-29

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• neonates with hypoxia.

You may not qualify if…

• hypoxic ischemic encephalopathy

Where it is running

• Sherief Abd-Elsalam — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.